Studies have revealed that exosomes obtained from CLL can modulate the tumour microenvironment by controlling Akt signalling and promoting the lofty expression of CLL promoters, including VEGF (vascular endothelial growth factor). This evidence concerns the gene AKT1 and B-cell chronic lymphocytic leukemia.